Recent molecular investigation revealed that two closely related structural genes encode distinct GDP-Lfucose:-D-galactoside 2-␣-L-fucosyltransferases (␣1,2-fucosyltransferases). Some human cancer cells or tissues may express an aberrant ␣1,2-fucosyltransferase other than H-and Secretor-type ␣1,2-fucosyltransferase. However, definite evidence of the existence of a third type of ␣1,2-fucosyltransferase has not been demonstrated. Here we report the molecular cloning of a third type of rabbit ␣1,2-fucosyltransferase (RFT-III) from a rabbit genomic DNA library. The DNA sequence included an open reading frame coding for 347 amino acids, and the deduced amino acid sequence of RFT-III showed 59 and 80% identity with those of the previously reported two types of rabbit ␣1,2-fucosyltransferase, RFT-I and RFT-II, respectively. COS-7 cells transfected with the RFT-III gene exhibited ␣1,2-fucosyltransferase activity toward phenyl--Gal as a substrate. Neuro2a (a murine neuroblastoma cell line) cells transfected with the RFT-III gene expressed fucosyl G M1 (type 3 H) but not Ulex europaeus agglutinin-1 lectin reactive antigens (type 2 H). Kinetic studies revealed that RFT-III exhibits higher affinity to types 1 (Gal1, 3GlcNAc) and 3 (Gal1, 3Gal-NAc) than to type 2 (Gal1, 4GlcNAc) oligosaccharides, which suggests that RFT-III as well as RFT-II is a Secretor-type ␣1,2-fucosyltransferase. RFT-III was expressed in the adult gastrointestinal tract. The RFT-I, -II, and -III genes were assigned within 90 kilobases on pulsed field gel electrophoresis analysis. These results constitute direct evidence that, at least in one mammalian species, three active ␣1,2-fucosyltransferases exist.1 catalyzes the fucosylation of terminal -DGal residues and synthesizes H antigens. The activity of ␣1,2-fucosyltransferase was detected in various tissues and body fluids of mammals that had several different kinetic characteristics (1-5). In humans, genetic and biochemical studies have indicated that two distinct but closely linked structural genes (H and Se) code ␣1,2-fucosyltransferases with tissue-specific patterns (1, 6). The human H gene controls the expression of H (Fuc␣1,2Gal) antigens (along with A or B antigens or both) on erythrocytes, whereas the Se gene determines the soluble A, B, and H antigens in secretory glands, and Lewis b blood group antigens on red cells (for review, see Ref. 7). Homozygosity for null alleles for the H and Se genes yields the rare Bombay blood type and non-Secretor phenotype, respectively. Recent molecular cloning of the H and Se genes provided the molecular basis for the Bombay and para-Bombay blood types and the nonSecretor phenotype, respectively, revealing point mutations within the coding regions that abolish the ␣1,2-fucosyltransferase activity (8 -10). On the other hand, the Lewis phenotyping of erythrocytes and secretory glands revealed the Le(aϩbϩ) and partial Secretor phenotypes in selected Polynesian and Asian individuals (11, 12). These phenotypes, which are virtually absent in Caucasians, are tho...